Phase II trial of nafamostat mesilate/gemcitabin/S-1 for unresectable pancreatic cancer

PURPOSE: To assess the efficacy of combination chemotherapy with nafamostat mesilate, gemcitabine and S-1 for unresectable pancreatic cancer patients. MATERIALS AND METHODS: The study was conducted as a single-arm, single center, institutional review board-approved phase II trial. Patients received...

Descripción completa

Detalles Bibliográficos
Autores principales: Uwagawa, Tadashi, Sakamoto, Taro, Gocho, Takeshi, Shiba, Hiroaki, Onda, Shinji, Yasuda, Jungo, Shirai, Yoshihiro, Hamura, Ryoga, Furukawa, Kenei, Yanaga, Katsuhiko, Ikegami, Toru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9094514/
https://www.ncbi.nlm.nih.gov/pubmed/35544539
http://dx.doi.org/10.1371/journal.pone.0267623

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9094514/
https://www.ncbi.nlm.nih.gov/pubmed/35544539
http://dx.doi.org/10.1371/journal.pone.0267623

Ejemplares similares